These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antituberculosis activity of the molecular libraries screening center network library. Maddry JA; Ananthan S; Goldman RC; Hobrath JV; Kwong CD; Maddox C; Rasmussen L; Reynolds RC; Secrist JA; Sosa MI; White EL; Zhang W Tuberculosis (Edinb); 2009 Sep; 89(5):354-63. PubMed ID: 19783214 [TBL] [Abstract][Full Text] [Related]
6. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G. Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226 [TBL] [Abstract][Full Text] [Related]
7. Lead selection and characterization of antitubercular compounds using the Nested Chemical Library. Sipos A; Pató J; Székely R; Hartkoorn RC; Kékesi L; Őrfi L; Szántai-Kis C; Mikušová K; Svetlíková Z; Korduláková J; Nagaraja V; Godbole AA; Bush N; Collin F; Maxwell A; Cole ST; Kéri G Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S200-6. PubMed ID: 25801335 [TBL] [Abstract][Full Text] [Related]
8. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
9. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model. Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471 [TBL] [Abstract][Full Text] [Related]
10. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944 [TBL] [Abstract][Full Text] [Related]
11. No Evidence for Acquired Mutations Associated with Cytochrome Rybniker J; Kohl TA; Barilar I; Niemann S Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323041 [No Abstract] [Full Text] [Related]
12. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism]. Egorov AM; Sazykin IuO Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346 [No Abstract] [Full Text] [Related]
14. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design. Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857 [TBL] [Abstract][Full Text] [Related]
15. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? Goldman RC Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636 [TBL] [Abstract][Full Text] [Related]
16. Leads for antitubercular compounds from kinase inhibitor library screens. Magnet S; Hartkoorn RC; Székely R; Pató J; Triccas JA; Schneider P; Szántai-Kis C; Orfi L; Chambon M; Banfi D; Bueno M; Turcatti G; Kéri G; Cole ST Tuberculosis (Edinb); 2010 Nov; 90(6):354-60. PubMed ID: 20934382 [TBL] [Abstract][Full Text] [Related]
17. Letting the genome out of the bottle: prospects for new drug development. Young D Ann N Y Acad Sci; 2001 Dec; 953():146-50. PubMed ID: 11795407 [TBL] [Abstract][Full Text] [Related]
18. Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria. Kanvatirth P; Jeeves RE; Bacon J; Besra GS; Alderwick LJ PLoS One; 2019; 14(3):e0213713. PubMed ID: 30861059 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]